Medical cannabis and mental health: A guided systematic review
This review considers the potential influences of the use of cannabis for therapeutic purposes (CTP) on areas of interest to mental health professionals, with foci on adult psychopathology and assessment. We identified 31 articles relating to the use of CTP and mental health, and 29 review articles...
Gespeichert in:
Veröffentlicht in: | Clinical psychology review 2017-02, Vol.51, p.15-29 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 29 |
---|---|
container_issue | |
container_start_page | 15 |
container_title | Clinical psychology review |
container_volume | 51 |
creator | Walsh, Zach Gonzalez, Raul Crosby, Kim S. Thiessen, Michelle Carroll, Chris Bonn-Miller, Marcel O. |
description | This review considers the potential influences of the use of cannabis for therapeutic purposes (CTP) on areas of interest to mental health professionals, with foci on adult psychopathology and assessment. We identified 31 articles relating to the use of CTP and mental health, and 29 review articles on cannabis use and mental health that did not focus on use for therapeutic purposes. Results reflect the prominence of mental health conditions among the reasons for CTP use, and the relative dearth of high-quality evidence related to CTP in this context, thereby highlighting the need for further research into the harms and benefits of medical cannabis relative to other therapeutic options. Preliminary evidence suggests that CTP may have potential for the treatment of PTSD, and as a substitute for problematic use of other substances. Extrapolation from reviews of non-therapeutic cannabis use suggests that the use of CTP may be problematic among individuals with psychotic disorders. The clinical implications of CTP use among individuals with mood disorders are unclear. With regard to assessment, evidence suggests that CTP use does not increase risk of harm to self or others. Acute cannabis intoxication and recent CTP use may result in reversible deficits with the potential to influence cognitive assessment, particularly on tests of short-term memory.
•Mental health conditions are prominent among the reasons for medical cannabis use.•Cannabis has potential for the treatment of PTSD and substance use disorders.•Cannabis use may influence cognitive assessment, particularly with regard to memory.•Cannabis use does not appear to increase risk of harm to self or others.•More research is needed to characterize the mental health impact of medical cannabis. |
doi_str_mv | 10.1016/j.cpr.2016.10.002 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1837025420</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0272735816300939</els_id><sourcerecordid>1837025420</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-d53ec8365da769f7644af01d06e9fd5bdfcd99602e3e9417fb3e55f74e5f12913</originalsourceid><addsrcrecordid>eNp9kMtKAzEUhoMotlYfwI3M0s2MucwkMwpCKd6g4kbXIZOc2JS51GRG6dubUnXp6lz4zg_nQ-ic4Ixgwq_Wmd74jMY2zhnG9ABNSSlYKkpCDtEUU0FTwYpygk5CWGOMSZmTYzShEeAlJlN0-wzGadUkWnWdql1IVGeSFroh7lagmmF1ncyT99EZMEnYhgFaNTidePh08HWKjqxqApz91Bl6u797XTymy5eHp8V8mWpW8iE1BQNdMl4YJXhlBc9zZTExmENlTVEbq01VcUyBQZUTYWsGRWFFDoUltCJshi73uRvff4wQBtm6oKFpVAf9GCQpmcC0yCmOKNmj2vcheLBy412r_FYSLHfa5FpGbXKnbbeK2uLNxU_8WLdg_i5-PUXgZg9AfDI-7mXQDjod5XnQgzS9-yf-G8DhfII</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1837025420</pqid></control><display><type>article</type><title>Medical cannabis and mental health: A guided systematic review</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Walsh, Zach ; Gonzalez, Raul ; Crosby, Kim ; S. Thiessen, Michelle ; Carroll, Chris ; Bonn-Miller, Marcel O.</creator><creatorcontrib>Walsh, Zach ; Gonzalez, Raul ; Crosby, Kim ; S. Thiessen, Michelle ; Carroll, Chris ; Bonn-Miller, Marcel O.</creatorcontrib><description>This review considers the potential influences of the use of cannabis for therapeutic purposes (CTP) on areas of interest to mental health professionals, with foci on adult psychopathology and assessment. We identified 31 articles relating to the use of CTP and mental health, and 29 review articles on cannabis use and mental health that did not focus on use for therapeutic purposes. Results reflect the prominence of mental health conditions among the reasons for CTP use, and the relative dearth of high-quality evidence related to CTP in this context, thereby highlighting the need for further research into the harms and benefits of medical cannabis relative to other therapeutic options. Preliminary evidence suggests that CTP may have potential for the treatment of PTSD, and as a substitute for problematic use of other substances. Extrapolation from reviews of non-therapeutic cannabis use suggests that the use of CTP may be problematic among individuals with psychotic disorders. The clinical implications of CTP use among individuals with mood disorders are unclear. With regard to assessment, evidence suggests that CTP use does not increase risk of harm to self or others. Acute cannabis intoxication and recent CTP use may result in reversible deficits with the potential to influence cognitive assessment, particularly on tests of short-term memory.
•Mental health conditions are prominent among the reasons for medical cannabis use.•Cannabis has potential for the treatment of PTSD and substance use disorders.•Cannabis use may influence cognitive assessment, particularly with regard to memory.•Cannabis use does not appear to increase risk of harm to self or others.•More research is needed to characterize the mental health impact of medical cannabis.</description><identifier>ISSN: 0272-7358</identifier><identifier>EISSN: 1873-7811</identifier><identifier>DOI: 10.1016/j.cpr.2016.10.002</identifier><identifier>PMID: 27816801</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Assessment ; Humans ; Medical cannabis ; Medical Marijuana - adverse effects ; Mental Health ; Psychopathology ; Substance use</subject><ispartof>Clinical psychology review, 2017-02, Vol.51, p.15-29</ispartof><rights>2016 Elsevier Ltd</rights><rights>Copyright © 2016 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-d53ec8365da769f7644af01d06e9fd5bdfcd99602e3e9417fb3e55f74e5f12913</citedby><cites>FETCH-LOGICAL-c386t-d53ec8365da769f7644af01d06e9fd5bdfcd99602e3e9417fb3e55f74e5f12913</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.cpr.2016.10.002$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27816801$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Walsh, Zach</creatorcontrib><creatorcontrib>Gonzalez, Raul</creatorcontrib><creatorcontrib>Crosby, Kim</creatorcontrib><creatorcontrib>S. Thiessen, Michelle</creatorcontrib><creatorcontrib>Carroll, Chris</creatorcontrib><creatorcontrib>Bonn-Miller, Marcel O.</creatorcontrib><title>Medical cannabis and mental health: A guided systematic review</title><title>Clinical psychology review</title><addtitle>Clin Psychol Rev</addtitle><description>This review considers the potential influences of the use of cannabis for therapeutic purposes (CTP) on areas of interest to mental health professionals, with foci on adult psychopathology and assessment. We identified 31 articles relating to the use of CTP and mental health, and 29 review articles on cannabis use and mental health that did not focus on use for therapeutic purposes. Results reflect the prominence of mental health conditions among the reasons for CTP use, and the relative dearth of high-quality evidence related to CTP in this context, thereby highlighting the need for further research into the harms and benefits of medical cannabis relative to other therapeutic options. Preliminary evidence suggests that CTP may have potential for the treatment of PTSD, and as a substitute for problematic use of other substances. Extrapolation from reviews of non-therapeutic cannabis use suggests that the use of CTP may be problematic among individuals with psychotic disorders. The clinical implications of CTP use among individuals with mood disorders are unclear. With regard to assessment, evidence suggests that CTP use does not increase risk of harm to self or others. Acute cannabis intoxication and recent CTP use may result in reversible deficits with the potential to influence cognitive assessment, particularly on tests of short-term memory.
•Mental health conditions are prominent among the reasons for medical cannabis use.•Cannabis has potential for the treatment of PTSD and substance use disorders.•Cannabis use may influence cognitive assessment, particularly with regard to memory.•Cannabis use does not appear to increase risk of harm to self or others.•More research is needed to characterize the mental health impact of medical cannabis.</description><subject>Assessment</subject><subject>Humans</subject><subject>Medical cannabis</subject><subject>Medical Marijuana - adverse effects</subject><subject>Mental Health</subject><subject>Psychopathology</subject><subject>Substance use</subject><issn>0272-7358</issn><issn>1873-7811</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtKAzEUhoMotlYfwI3M0s2MucwkMwpCKd6g4kbXIZOc2JS51GRG6dubUnXp6lz4zg_nQ-ic4Ixgwq_Wmd74jMY2zhnG9ABNSSlYKkpCDtEUU0FTwYpygk5CWGOMSZmTYzShEeAlJlN0-wzGadUkWnWdql1IVGeSFroh7lagmmF1ncyT99EZMEnYhgFaNTidePh08HWKjqxqApz91Bl6u797XTymy5eHp8V8mWpW8iE1BQNdMl4YJXhlBc9zZTExmENlTVEbq01VcUyBQZUTYWsGRWFFDoUltCJshi73uRvff4wQBtm6oKFpVAf9GCQpmcC0yCmOKNmj2vcheLBy412r_FYSLHfa5FpGbXKnbbeK2uLNxU_8WLdg_i5-PUXgZg9AfDI-7mXQDjod5XnQgzS9-yf-G8DhfII</recordid><startdate>201702</startdate><enddate>201702</enddate><creator>Walsh, Zach</creator><creator>Gonzalez, Raul</creator><creator>Crosby, Kim</creator><creator>S. Thiessen, Michelle</creator><creator>Carroll, Chris</creator><creator>Bonn-Miller, Marcel O.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201702</creationdate><title>Medical cannabis and mental health: A guided systematic review</title><author>Walsh, Zach ; Gonzalez, Raul ; Crosby, Kim ; S. Thiessen, Michelle ; Carroll, Chris ; Bonn-Miller, Marcel O.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-d53ec8365da769f7644af01d06e9fd5bdfcd99602e3e9417fb3e55f74e5f12913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Assessment</topic><topic>Humans</topic><topic>Medical cannabis</topic><topic>Medical Marijuana - adverse effects</topic><topic>Mental Health</topic><topic>Psychopathology</topic><topic>Substance use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Walsh, Zach</creatorcontrib><creatorcontrib>Gonzalez, Raul</creatorcontrib><creatorcontrib>Crosby, Kim</creatorcontrib><creatorcontrib>S. Thiessen, Michelle</creatorcontrib><creatorcontrib>Carroll, Chris</creatorcontrib><creatorcontrib>Bonn-Miller, Marcel O.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical psychology review</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Walsh, Zach</au><au>Gonzalez, Raul</au><au>Crosby, Kim</au><au>S. Thiessen, Michelle</au><au>Carroll, Chris</au><au>Bonn-Miller, Marcel O.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Medical cannabis and mental health: A guided systematic review</atitle><jtitle>Clinical psychology review</jtitle><addtitle>Clin Psychol Rev</addtitle><date>2017-02</date><risdate>2017</risdate><volume>51</volume><spage>15</spage><epage>29</epage><pages>15-29</pages><issn>0272-7358</issn><eissn>1873-7811</eissn><abstract>This review considers the potential influences of the use of cannabis for therapeutic purposes (CTP) on areas of interest to mental health professionals, with foci on adult psychopathology and assessment. We identified 31 articles relating to the use of CTP and mental health, and 29 review articles on cannabis use and mental health that did not focus on use for therapeutic purposes. Results reflect the prominence of mental health conditions among the reasons for CTP use, and the relative dearth of high-quality evidence related to CTP in this context, thereby highlighting the need for further research into the harms and benefits of medical cannabis relative to other therapeutic options. Preliminary evidence suggests that CTP may have potential for the treatment of PTSD, and as a substitute for problematic use of other substances. Extrapolation from reviews of non-therapeutic cannabis use suggests that the use of CTP may be problematic among individuals with psychotic disorders. The clinical implications of CTP use among individuals with mood disorders are unclear. With regard to assessment, evidence suggests that CTP use does not increase risk of harm to self or others. Acute cannabis intoxication and recent CTP use may result in reversible deficits with the potential to influence cognitive assessment, particularly on tests of short-term memory.
•Mental health conditions are prominent among the reasons for medical cannabis use.•Cannabis has potential for the treatment of PTSD and substance use disorders.•Cannabis use may influence cognitive assessment, particularly with regard to memory.•Cannabis use does not appear to increase risk of harm to self or others.•More research is needed to characterize the mental health impact of medical cannabis.</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>27816801</pmid><doi>10.1016/j.cpr.2016.10.002</doi><tpages>15</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0272-7358 |
ispartof | Clinical psychology review, 2017-02, Vol.51, p.15-29 |
issn | 0272-7358 1873-7811 |
language | eng |
recordid | cdi_proquest_miscellaneous_1837025420 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Assessment Humans Medical cannabis Medical Marijuana - adverse effects Mental Health Psychopathology Substance use |
title | Medical cannabis and mental health: A guided systematic review |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T18%3A04%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Medical%20cannabis%20and%20mental%20health:%20A%20guided%20systematic%20review&rft.jtitle=Clinical%20psychology%20review&rft.au=Walsh,%20Zach&rft.date=2017-02&rft.volume=51&rft.spage=15&rft.epage=29&rft.pages=15-29&rft.issn=0272-7358&rft.eissn=1873-7811&rft_id=info:doi/10.1016/j.cpr.2016.10.002&rft_dat=%3Cproquest_cross%3E1837025420%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1837025420&rft_id=info:pmid/27816801&rft_els_id=S0272735816300939&rfr_iscdi=true |